Genzyme [1] says its profit jumped tenfold to $159.3 million on rising sales of meds for rare genetic diseases. Report [2]
Links:[1] http://www.fiercebiotech.com/tags/genzyme [2] http://www.boston.com/business/markets/articles/2007/10/25/
